[1]
“Indications for the Use of Local Protective Factors in Patients Treated for Phlegmoma of the Maxillofacial Region”, AJPMHS, vol. 2, no. 1, pp. 23–27, Jan. 2024, Accessed: Jan. 16, 2026. [Online]. Available: https://grnjournal.us/index.php/AJPMHS/article/view/2510